Home › Funds › PSP Research LLC › COGT

PSP Research LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

PSP Research LLC reported holding 12,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$464K, representing 0.25% of its reported portfolio and ranking #25 among its reported holdings. PSP Research LLC has disclosed COGT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)12.00K sh
Reported value held$464.40K
Portfolio Weight0.25%
First reportedQ4 2025
Last changeNew

How PSP Research LLC's COGT position evolved

PSP Research LLC first disclosed a stake in COGT in Q4 2025 at 13,233 shares (US$470K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 12,000 shares valued at US$464K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 13.23K $470.04K New
Q1 2026 12.00K $461.88K Reduce
Q2 2026 12.00K $464.40K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 60 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →